MedTrace Logo

Diabetic Retinopathy Screening in General Practice

NCT05276778 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2025-05-06

No results posted yet for this study

Summary

Diabetic Retinopathy is a microvascular eye complication of diabetes, which can go unnoticed until permanent vision damage has occurred - in worst-case blindness. Timely retinopathy screenings reduce the risk of sight loss since the disease can be treated if detected in time. For people with type 2 diabetes, retinopathy screenings are typically performed by specialist at private ophthalmologists' practices, and individualized screening intervals based on retinopathy level and diabetes regulation are recommended. Unfortunately, 26% of people with type 2 diabetes do not follow their screening interval, and the attendance is too low compared to the national standard of minimum 90% of patients with diabetes who ought to follow the screening program. Consequently, actions must be taken to improve screening attendance in Denmark.

The aim of this study is to investigate patients' acceptance of diabetic retinopathy screenings in general practice. Patients' acceptance is explored through a questionnaire developed for the study.

Conditions

Interventions

DIAGNOSTIC_TEST

Diabetic Retinopathy Screening

Screenings are performed in the diabetes consultation in general practice

Sponsors & Collaborators

  • Aalborg University

    lead OTHER

Principal Investigators

  • Malene Krogh · Aalborg University

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-28
Primary Completion
2023-11-14
Completion
2023-11-14

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05276778 on ClinicalTrials.gov